Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Aurélie Collignon"'
Autor:
Carole Siret, Aurélie Collignon, Françoise Silvy, Stéphane Robert, Thierry Cheyrol, Perrine André, Véronique Rigot, Juan Iovanna, Serge van de Pavert, Dominique Lombardo, Eric Mas, Anna Martirosyan
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising incidence and a remarkable resistance to current therapies. The reasons for this therapeutic failure include the tumor's extensive infiltration by immunosuppressive cells such as
Externí odkaz:
https://doaj.org/article/521dadb697b543e381156702c22814fb
Autor:
Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas, Evelyne Beraud
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Pancreatic adenocarcinoma (PAC) has a poor prognosis. One treatment approach, investigated here, is to reinforce antitumor immunity. Dendritic cells (DCs) are essential for the development and regulation of adaptive host immune responses against tumo
Externí odkaz:
https://doaj.org/article/64caf32902694b35a6197ca1d25f0fab
Autor:
Alex Trinh, Marion Olive, Aurélie Collignon, Maité Chamourin, Georgia Culley, Clemence Jaume, Vanina Leca, Assil Benchaaben, Giovanni Bussotti, Alboukadel Kassambara, Jerome Galon, Jacques Fieschi
Publikováno v:
Cancer Research. 83:4624-4624
Tumor-infiltrating immune cells play an important role against cancer and are critical to control tumor growth and spread. Immunotherapy and immune checkpoint blockade, which aim to reinvigorate exhausted T cells have revolutionized cancer therapy. D
Autor:
Christophe Haond, Clémence Jaume, Dylan Anselmo, Georgia Culey, Raana Ramouz-Charpentier, Marion Olive, Aurélie Collignon, Nour Sfeir, Jérôme Galon, Maïté Chamourin, Alex Trinh, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCancer immunotherapy reinvigorates tumor-specific T cell responses of CD8+ cytotoxic T lymphocytes that detect intracellular antigens that are presented by MHC class I molecules expressed by all tumor cell types. Because most tumors do not
Autor:
Françoise Silvy, Aurélie Collignon, Dominique Lombardo, Emmanuelle Martinez, Evelyne Beraud, Isabelle Crenon, Eric Mas
Publikováno v:
Oncotarget
// Dominique Lombardo 1 , Francoise Silvy 1 , Isabelle Crenon 1 , Emmanuelle Martinez 1 , Aurelie Collignon 1 , Evelyne Beraud 1 and Eric Mas 1 1 Aix Marseille Univ, INSERM, CRO2, Centre de Recherche en Oncologie Biologique et Oncopharmacologie, Mars
Autor:
Alex Trinh, Jérôme Galon, Dylan Anselmo, Jacques Fieschi-Meric, Marion Olive, Clémence Jaume, Nour Sfeir, Maïté Chamourin, Christophe Haond, Raana Ramouz-Charpentier, Georgia Culey, Aurélie Collignon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundDensity and localization of T cells within the tumor microenvironment (TME) is critical to control tumor growth. Immunotherapy with antibodies against immune checkpoint inhibitors (ICI), which aim to reinvigorate exhausted T cells, despite
Autor:
Jerome Galon, Jacques Fieschi, Aurelie Collignon, Alex Trinh, Marion Olive, Maïté Chamourin, Alboukadel Kassambara, Lucie Sudre, Anthony Lebret, Giovanni Bussoti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2d9298d5c7240a39def59423ac5341c
Autor:
Aurélie Collignon, Assil Benchaaben, Alboukadel Kassambara, Felipe Guimaraes, Emmanuel Prestat, Christophe Haond, Jacques Fieschi
Publikováno v:
Cancer Research. 79:2796-2796
Brightplex is a multiplexing solution developed by HalioDx to analyze the tumor microenvironment on FFPE tissue. It leverages chromogenic immunohistochemistry performed by iterative automated immunostaining on the same slide followed by whole slide d
Autor:
Jacques Fieschi, Christophe Haond, Aurélie Collignon, Anna Martirosyan, Assil Benchaaben, Emilie Bonzom, Emmanuel Prestat, Matthieu Duval
Publikováno v:
Cancer Immunology Research. 7:A182-A182
Cancer immunotherapy by anti-PD-1 or anti-PD-L1 antibodies is now established as an efficient approach to restore the cytotoxic activity of exhausted T-cells. However, the strong and durable response observed in non-small cell lung cancer (NSCLC) pat
Autor:
Evelyne Beraud, Dominique Lombardo, Aurélie Collignon, Eric Mas, Cécile Franceschi, Daniel Olive
Publikováno v:
Oncoimmunology
Glycoproteins, as valuable targets for dendritic cell (DC)-vaccination in cancers, remain an open question. Glycosylated structures, which are aberrantly modified during cancerisation, impact positively or negatively on glycoprotein immunogenicity. H